Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	91.25	-31.34	-357.92
Graham Fair Price	51.55	27.42	18.09
PEG	-42.25	< 0.005	0.01
Price/Book	-7.41	0.11	0.12
Price/Cash Flow	67.54	-1.06	-3.26
Prices/Earnings	59.68	-1.05	-2.60
Price/Sales	-53.70	2.27	4.91
Price/FCF	67.54	-1.06	-3.26
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-3.50	0.37	0.38
Operating Margin	-376.20	-0.90	-0.19
ROA	-129.67	< 0.005	< 0.005
ROE	-0.01	-0.03	-129.67
ROIC	< 0.005	-0.02	-884.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.05	0.10	-46.58
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.76	-8.52	1021.14
EPS QOQ	-1.81	-1.26	30.19
FCF QOQ	0.40	-1.85	359.54
Revenue QOQ	0.81	1.00	23.04
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	12481.26	6109.35	-51.05
Days Sales Outstanding (DSO)	0.98	118.53	12002.40
Inventory Turnover	< 0.005	0.01	104.30
Debt/Capitalization	0.60	0.59	-2.25
Quick Ratio	0.14	0.26	81.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	35.05	35.05	< 0.005
Cash	5.93	8.48	43.10
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	-1.32	-3.77	-185.22
Revenue	0.88	1.76	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.21	2.21	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-327.60	-28.71	91.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating